PAI offers employer groups the services they need to get the most from their self-funded plan or other employee benefit solution, including limited benefits, and voluntary products that help complement major medical coverage.
Each PAI client is supported by a team of professionals who take care of the details. From implementation and open enrollment, through day-to-day service and compliance, to helping analyze and review claims data and offer potential solutions. PAI provides a level of service that far exceeds the ordinary TPA.
Covered plan members can take advantage of savings including Preferred Provider network discounts, Pharmacy discounts, and other value-added programs.
"I believe in personally reaching out to our employer groups on a regular basis to keep a finger on the pulse of our performance."
Lisa Watters, Operations Supervisor
Oct. 15, 2018
The changes in this bulletin go into effect January 1, 2019, unless noted otherwise. They apply to PAI groups that use the Caremark Preferred Drug List.
Oct. 10, 2018
CVS Pharmacy, CVS Pharmacy Specialty Services, CVS Caremark operations, Coram, AccordantCare, and Omnicare sites are ensuring colleague and member safety, monitoring structural soundness, and working with customers to ensure medication needs are met.
Sep. 28, 2018
This is an update to coverage of the drug Victoza. It applies to self-funded PAI groups with Caremark Pharmacy benefits.
Sep. 12, 2018
Please see the following update from CVS regrading pharmacy closings due to Hurricane Florence. Information on other network pharmacies will also be available at the link provided.
Sep. 10, 2018
As of September 7, 2018, a Governor’s Declaration of Emergency was issued for North Carolina due to severe weather. On September 8, a Governor’s Declaration of Emergency was issued for South Carolina.
Sep. 04, 2018
By contract, pharmacy benefit coverage does not include multivitamin products. However, we have been covering several folic acid/folate vitamin products that should have been considered benefit exclusions.
Jul. 19, 2018
The changes in this bulletin go into effect October 1, 2018, unless noted otherwise. They apply to PAI groups that use the Caremark Preferred Drug List.
May. 29, 2018
On March 2, 2018, the manufacturers of Zinbryta (daclizumab) – a drug used in the treatment of some forms of multiple sclerosis – announced that they would stop making the drug because of concerns about serious side effects.
May. 25, 2018
PAI is excited to introduce a new Preferred Blue provider (PPO) network logo.
May. 25, 2018
The changes in this bulletin apply to all groups that use the PAI Preferred Drug List.